BEONE MEDICINES LTD. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
BEONE MEDICINES LTD. (ONC) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $42.24 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2026-02-26
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $42.24M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $38.40M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $26.69M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $19.70M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost |
|---|---|
| 2025-12-31 | $42.24M 10-K · filed 2026-02-26 |
| 2024-12-31 | $38.40M 10-K · filed 2026-02-26 |
| 2023-12-31 | $26.69M 10-K · filed 2026-02-26 |
| 2022-12-31 | $19.70M 10-K · filed 2025-02-27 |
| 2021-12-31 | $14.98M 10-K · filed 2024-02-26 |
| 2020-12-31 | $13.98M 10-K · filed 2023-02-27 |
| 2019-12-31 | $12.65M 10-K · filed 2022-02-28 |
| 2018-12-31 | $8.64M 10-K · filed 2021-02-25 |
| 2017-12-31 | $4.64M 10-K · filed 2020-03-02 |
| 2016-12-31 | $0.00 10-K · filed 2019-02-28 |